Evidence map›Paper›PMID 19814792›Full record

ArticleBMC biotechnology2009

Characterization of unknown genetic modifications using high throughput sequencing and computational subtraction.

Torstein Tengs, Haibo Zhang, Arne Holst-Jensen, Jon Bohlin, Melinka A Butenko, Anja Bråthen Kristoffersen, Hilde-Gunn Opsahl Sorteberg, Knut G Berdal

Abstract read
In one paragraph

Article in BMC biotechnology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Torstein TengsNational Veterinary Institute, Oslo, Norway. Torstein.tengs@vetinst.no
Haibo Zhang
Arne Holst-Jensen
Jon Bohlin
Melinka A Butenko
Anja Bråthen Kristoffersen
Hilde-Gunn Opsahl Sorteberg
Knut G Berdal

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhen generating a genetically modified organism (GMO), the primary goal is to give a target organism one or several novel traits by using biotechnology techniques. A GMO will differ from its parental strain in that its pool of transcripts will be altered. Currently, there are no methods that are reliably able to determine if an organism has been genetically altered if the nature of the modification is unknown.

resultsWe show that the concept of computational subtraction can be used to identify transgenic cDNA sequences from genetically modified plants. Our datasets include 454-type sequences from a transgenic line of Arabidopsis thaliana and published EST datasets from commercially relevant species (rice and papaya).

conclusionWe believe that computational subtraction represents a powerful new strategy for determining if an organism has been genetically modified as well as to define the nature of the modification. Fewer assumptions have to be made compared to methods currently in use and this is an advantage particularly when working with unknown GMOs.

Indexed as

ArabidopsisComputational BiologyDNA, ComplementaryExpressed Sequence TagsGene LibraryGenetic EngineeringPlants, Genetically ModifiedRNA, PlantSequence Analysis, RNADNA, ComplementaryRNA, Plant

Identifiers

PMID19814792
PMCPMC2764706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.